Zobrazeno 1 - 9
of 9
pro vyhledávání: '"E. V. Luchinina"'
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 15-25 (2023)
Multiple myeloma (MM) accounts for 1 % of all cancers and about 10 % of all hemoblastoses. The use of innovative technologies with the inclusion of targeted drugs leads to a significant improvement in the quality of pharmacotherapy and the achievemen
Externí odkaz:
https://doaj.org/article/84887573e1e043e4b7fa05d5a39873dd
Autor:
M. V. Zhuravleva, G. V. Kukushkin, E. V. Luchinina, T. V. Shelekhova, T. R. Kameneva, E. V. Kuznetsova, E. A. Luchinin
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 41-52 (2022)
Relevance. Ademetionine is a hepatoprotective drug, is included in the draft Russian clinical guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease (NAFLD) and in the clinical guidelines for treating intrahepatic cholestasis
Externí odkaz:
https://doaj.org/article/4764411672e14f94a71c914d6b7d389e
Autor:
M. V. Zhuravleva, E. V. Luchinina, T. V. Shelekhova, S. Yu. Serebrova, S. A. Belkov, A. I. Dmitriev, G. I. Gorodetskaya
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 4, Pp 601-606 (2020)
Modern tactics of treatment of arterial hypertension (AH) involves the use of both monotherapy and combination therapy. Monotherapy is recommended primarily for low-risk patients with systolic blood pressure (BP)< 150 mm Hg. Monotherapy should also b
Externí odkaz:
https://doaj.org/article/950925bd547a4074adca1131e1cb5152
Autor:
R. A. Bontsevich, A. A. Gavrilova, Y. R. Vovk, A. V. Adonina, N. Y. Goncharova, G. G. Prozorova, O. G. Kompaniets, V. O. Barysheva, G. G. Ketova, E. N. Bochanova, E. V. Mironenko, T. M. Shagiyeva, A. A. Kirichenko, I. F. Krotkova, E. A. Shabanov, U. M. Tilekeyeva, E. V. Luchinina, I. P. Galkina, M. L. Maksimov, V. A. Nevzorova
Publikováno v:
Medičnì Perspektivi, Vol 25, Iss 1, Pp 59-65 (2020)
Community-acquired pneumonia (CAP) is one of the most relevant problems of modern medicine. Today, CAP takes 4th place in the structure of mortality (after cardiovascular, cerebrovascular diseases and malignant neoplasms) and 1st place among all de
Externí odkaz:
https://doaj.org/article/4d2016b75bc441cfb0fed61c98bfe164
Publikováno v:
Medical alphabet. :7-11
The aim of the study was to assess the tolerability and impact on the quality of life of pharmacotherapy for gastric ulcer, erosive gastritis using regimens including rebamipide. The quality of life of patients was assessed using the SF-36 questionna
Autor:
S. A. Belkov, G. I. Gorodetskaya, M. V. Zhuravleva, A. I. Dmitriev, E. V. Luchinina, T. V. Shelekhova, S. Yu. Serebrova
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 16, Iss 4, Pp 601-606 (2020)
Modern tactics of treatment of arterial hypertension (AH) involves the use of both monotherapy and combination therapy. Monotherapy is recommended primarily for low-risk patients with systolic blood pressure (BP)< 150 mm Hg. Monotherapy should also b
Publikováno v:
Системные гипертензии, Vol 14, Iss 3, Pp 79-83 (2017)
Arterial hypertension and dyslipidemia is a very frequent comorbid condition. Arterial hypertension and dyslipidemia are combined in 40-70% of patients. The statins is the basic drug in primary and secondary prevention of cardiovascular disease and i
Autor:
E. V. Luchinina, M. V. Davydovskaya, D. O. Kurguzova, M. V. Zhuravleva, S. Yu. Serebrova, T. V. Shelekhova
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 120:148
This review aims at describing clinical benefits and characteristics of the main highly effective disease modifying drugs (DMD) for multiple sclerosis (MS): alemtuzumab, cladribine tablets, ocrelizumab, natalizumab, fingolimod based on the efficacy a
Autor:
R. A Bontsevich, A. V Adonina, Y. R Vovk, G. A Batisheva, O. V Cherenkova, G. G. Ketova, V. O Barysheva, E. V Luchinina, T. G Pokrovskaia
Publikováno v:
Archives of Razi Institute, Vol 77, Iss 1, Pp 439-447 (2022)
The relevance of the study of chronic obstructive pulmonary disease (COPD) can be explained by the persistence of unfavorable dynamics of the disease, even despite the achieved success in the pharmacotherapy of this pathology. In 2016, World Health O
Externí odkaz:
https://doaj.org/article/3b435cbdc22645de969319ea050c8fe4